Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: 9 | Rare Historical Photos

2 No-Brainer Biotech Stocks to Buy Right Now and 1 to Sell

The biotech industry is set to benefit from continued investments in breakthrough developments and federal support. Against this backdrop, fundamentally strong biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) could be solid buys. However, Relmada Therapeutics (RLMD) might be best avoided considering its weak fundamentals. Read on….

StockNews.com

Will cell-based milk change the dairy industry? This California lab could lead the way

Biotechnology startup TurtleTree wants to change the way people consume milk.

Tribune News Service

Give legal rights to animals, trees and rivers, say experts

Report for Law Society says framework is essential for future interactions with the environment and biotechnology

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

New rice strain able to tolerate flooding

A research team from the National Centre for Genetic Engineering and Biotechnology (Biotec) has succeeded in developing a new rice strain called Hom Le Noi that can reportedly withstand the effects of flooding.

Bangkok Post

3 Biotech Stocks That'll Make You Richer and 1 That Won't

The biotech industry continues to stay resilient to broader economic challenges. Moreover, the planned multi-million-dollar government investments should bode well for the industry. Hence, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) could be ideal buys to cash in on the industry’s prospects. However, fundamentally weak stock…

StockNews.com

New method of preserving donated kidneys ‘could mean fewer organs wasted’

The technique could keep kidneys viable for longer and increase the number available for transplant.

The Independent UK

Who’s Afraid of Gene-Edited Crops?

A new U.K. bill is a chance at food security—if Britain can get past unfounded fears.

Foreign Policy

Read news from The Economist, FT, and more,
with one subscription

MingMed Biotech Joins Queue of Revenue-less Drug Startups Seeking IPO Cash

Key Takeaways: With no drug revenues and growing R&D costs, MingMed Biotechnology plans to feed its cash-burning machine with a Hong Kong IPO Company has seven drugs in development, including six in the clinical stages By Ellie Si

Benzinga

Agricultural firms urged to accelerate tech adoption

Thai food and agricultural companies are being advised to boost their productivity and food safety through the application of Internet of Things, robotics in value chains, and drone technology for plantation and agricultural biotechnology such as genetic engineering.

Bangkok Post

$7.3 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones dropped more than 600 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

Benzinga

Riyadh, Tashkent to Expand Cooperation in Tech, Petrochemical Industries

Ahead of the visit of Uzbek President Shavkat Mirziyoyev to Saudi Arabia, the embassy of Uzbekistan in Riyadh expected a rapid and dynamic development of bilateral cooperation between the two countries. Cooperation is expected in the fields of energy, information technology, telecommunications, health, biotechnology and agriculture, in addition to forestry,…

Asharq Al-Awsat

5 Biotech Stocks in the Buy Zone This Week

The biotech industry is expected to see solid growth in the long term due to rising healthcare spending, breakthrough developments, and an aging population. Given the industry’s solid growth prospects and non-cyclical nature, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), Biogen (BIIB), Jazz…

StockNews.com

Recap Of Friday's Biotech Catalysts - End Of the Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD). The study met two co-primary objectives, associated with immunogenicity responses. Pfizer shares traded in a range of $48.55 to…

Benzinga

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Don't Rule out a Summer Rally for This 1 Biotech Stock

Leading biotechnology company Vertex Pharmaceuticals (VRTX) has achieved strong top and bottom-line growth in its last quarter. Furthermore, the company is well-positioned to benefit from its diversified pipeline of transformative small-molecule, cell, and genetic therapies. Thus, even after gaining 27.5% year-to-date, we think VRTX still has decent upside potential. Read…

StockNews.com

5 Biotech Stocks to Buy and Hold for the Next Decade

The biotech industry seems poised to witness solid growth over the next decade with intensive innovation, breakthrough developments, and growing investments in the sector. So, given analysts’ promising growth outlook for the industry, it could be wise for investors to buy and hold fundamentally solid biotech stocks Vertex Pharmaceuticals (VRTX),…

StockNews.com

4 Downgraded Stocks You'll Want to Sell or Avoid Right Now

With the growing odds of the economy tipping into a recession due to an aggressive monetary policy tightening to tame the sky-high inflation, it could be difficult for fundamentally weak stocks to stay afloat. Invesco (IVZ), Kymera (KYMR), Mogo (MOGO), and Sana Biotechnology (SANA) have been recently downgraded by our…

Reuters

Bavarian Nordic monkeypox vaccine wins EU approval

Danish biotechnology company Bavarian Nordic said on Monday the European Commission had given permission for its Imvanex vaccine to be marketed as protection against monkeypox, as recommended last week by the European Medicines Agency (EMA).

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Genetically modified cowpea clears its first hurdle in Ghana, but there's a long way to go

Genetically modified (GM) cowpea has cleared the first of the three regulatory hurdles in the way of commercialisation in Ghana. If it is commercialised, it will be the first GM crop grown in the country – a major milestone. Biotechnology proponents have been working for decades to integrate GM crops…

The Hindu

Gujarat woos biotech firms in Telangana

Holds roadshow in city on its new Biotechnology Policy

Bangkok Post

Tisco Bank unit touts healthcare, biotech

Tisco Bank's wealth advisory unit suggests moving away from energy stocks to biotechnology and healthcare as several US economic indicators have signalled a higher risk of recession.

The Conversation

How Nigeria can turn its huge cashew waste into valuable citric acid

Nigeria – the sixth largest producer of cashew nuts globally – exports more than 80% of its raw cashews primarily to Vietman and India where they are processed into various consumer products such as butter, food and cosmetic ingredients.

The Times of India

All higher educational institutions in Tamil Nadu should follow 69% quota in admissions: Minister K Ponmudy

CHENNAI: All higher educational institutions in the state should follow 69% reservation system in admissions, higher education minister K Ponmudy said on Tuesday following opposition from political parties in the state to reserving seats under economically weaker section (EWS) quota in MSc Biotechnology programme offered at Madurai Kamaraj University.

Benzinga

MorphoSys Stock Skyrockets On Entering Equity Participation and License Agreements With HIBio

MorphoSys AG (NASDAQ:MOR) and Human Immunology Biosciences, Inc. (HIBio), a biotechnology company, have established an equity participation agreement and license agreements to allow HIBio to develop and commercialize MorphoSys’ felzartamab, an anti-CD38 antibody, and MOR210, an anti-C5aR1 antibody. HIBio is a biotechnology company based in South San Francisco that focuses on discovering and…

Benzinga

Donaldson Acquires Early-Stage Biotechnology Company Purilogics

Donaldson Company, Inc. (NYSE:DCI) has acquired Purilogics, LLC, an early-stage biotechnology company, for an initial purchase price of $20 million plus milestone-based earnout payments over the next five years. Founded in 2013 by Jinxiang Zhou and Scott Husson, Purilogics is based in Greenville, South Carolina. Purilogics offers a broad portfolio of purification…

1 … 7 8 9 10

People

Dipanjan BanchurSince

722 stories

Luke

624 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.